Spyre Therapeutics, Inc. short interest in 2025
In 2025, Spyre Therapeutics, Inc.'s disclosed short interest ran from 19.45% of shares outstanding on 15 Jan 2025 to 15.00% on 31 Dec 2025, a change of -4.45 percentage points. The year's high was 24.41% on 30 Apr 2025 and its low 14.38% on 28 Nov 2025, averaging 20.28% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 33.21 days on 30 May 2025. Full history: Spyre Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 19.45% (15 Jan 2025)
- End of year
- 15.00% (31 Dec 2025)
- Change
- -4.45 pp
- High
- 24.41% (30 Apr 2025)
- Low
- 14.38% (28 Nov 2025)
- Average
- 20.28%
- Highest days to cover
- 33.21 (30 May 2025)
- SEC filings marked
- 10
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 19.45% | 18.05 | results (8-K) |
| 31 Jan 2025 | 19.90% | 16.75 | |
| 14 Feb 2025 | 19.30% | 17.06 | |
| 28 Feb 2025 | 19.49% | 16.08 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 20.94% | 16.08 | |
| 31 Mar 2025 | 22.09% | 17.61 | |
| 15 Apr 2025 | 22.85% | 11.52 | |
| 30 Apr 2025 | 24.41% | 21.38 | |
| 15 May 2025 | 20.37% | 20.75 | 10-Q filed, results (8-K) |
| 30 May 2025 | 20.03% | 33.21 | |
| 13 Jun 2025 | 20.86% | 27.28 | |
| 30 Jun 2025 | 22.35% | 16.95 | |
| 15 Jul 2025 | 22.54% | 23.13 | |
| 31 Jul 2025 | 21.32% | 23.35 | |
| 15 Aug 2025 | 21.83% | 30.50 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 23.32% | 29.35 | |
| 15 Sep 2025 | 22.82% | 28.53 | |
| 30 Sep 2025 | 23.94% | 18.19 | |
| 15 Oct 2025 | 22.17% | 9.19 | results (8-K) |
| 31 Oct 2025 | 15.99% | 11.89 | |
| 14 Nov 2025 | 16.06% | 20.15 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 14.38% | 18.26 | |
| 15 Dec 2025 | 15.23% | 13.87 | |
| 31 Dec 2025 | 15.00% | 14.06 |
See also: Spyre Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.